The fund will invest at least 80% of its net assets in derivatives contracts that utilize the Underlying Leveraged ETF as their reference asset. It is non-diversified.
Frequently asked questions
What sector does GraniteShares YieldBOOST CRCL ETF (CRY) operate in?
GraniteShares YieldBOOST CRCL ETF belongs to the Healthcare sector.
What is GraniteShares YieldBOOST CRCL ETF (CRY) current stock price?
As of the latest data, GraniteShares YieldBOOST CRCL ETF stock price is $15.04, with a previous close of $15.16. GraniteShares YieldBOOST CRCL ETF lost -$0.12 in the last trading session, representing a -0.78% loss.
What is GraniteShares YieldBOOST CRCL ETF (CRY) current market capitalization?
GraniteShares YieldBOOST CRCL ETF market cap is approximately 591.60 million.
What is GraniteShares YieldBOOST CRCL ETF (CRY) Earnings Per Share (EPS)?
The trailing EPS is $0.04, and the forward EPS is $0.07.
What is GraniteShares YieldBOOST CRCL ETF (CRY) Price-to-Earnings (P/E) ratio?
GraniteShares YieldBOOST CRCL ETF current P/E ratio is 358.14, with a forward P/E of 214.89.
Does GraniteShares YieldBOOST CRCL ETF (CRY) pay dividends?
Yes. GraniteShares YieldBOOST CRCL ETF pays weekly dividends with an annualized yield of 87.81% and an estimated annual payout of $13.21 per share.
When is the next ex-dividend date for GraniteShares YieldBOOST CRCL ETF (CRY)?
The next ex-dividend date is scheduled for October 23, 2026.
What is GraniteShares YieldBOOST CRCL ETF (CRY) beta (volatility) score?
GraniteShares YieldBOOST CRCL ETF has a beta of 0.000, indicating lower volatility than the overall market.